
Nvixo-S 1.5 Injection
Marketer
Vinsha Pharmaceuticals
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Nvixo-S 1.5 Injection
Injex-B 1.5 is a multi-component medication used to combat diverse bacterial infections. Its mechanism involves inhibiting microbial proliferation and halting infection progression. Administration of Injex-B 1.5 Injection must be overseen by a medical professional. Consistent adherence to the prescribed dosage schedule is crucial; complete the entire treatment course, regardless of symptom improvement. Premature cessation may compromise efficacy. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Significant worsening of any side effect necessitates immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., skin rashes, pruritus, edema, respiratory distress). Inform your physician about all current medications before commencing Injex-B 1.5 Injection. Pregnant or lactating individuals should seek medical advice prior to use. Alcohol consumption should be avoided due to potential for increased somnolence. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration are recommended for optimal recovery. Your doctor may order laboratory and imaging tests to monitor the medication's effects.
Primary Ingredients of Nvixo-S 1.5 Injection
No text provided. Please provide the text you wish me to rephrase.
Uses of Nvixo-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Nvixo-S 1.5 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Nvixo-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Nvixo-S 1.5 Injection:
The medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Nvixo-S 1.5 Injection works:
Nvixo-S 1.5 Injection unites Ceftriaxone, a bacterial growth inhibitor, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with concurrent alcohol and Nvixo-S 1.5 Injection use.
PregnancySAFE IF PRESCRIBED
The injectable medication Nvixo-S 1.5 is typically deemed safe for pregnant individuals. Preclinical trials using animals revealed minimal or no negative consequences for fetal development; yet, data from human trials are scarce.
Breast feedingCAUTION
Administering Nvixo-S 1.5 Injection to breastfeeding mothers requires careful consideration. Lactation should be discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
The administration of Nvixo-S 1.5 Injection can induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Nvixo-S 1.5 Injection's use in individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Administering Nvixo-S 1.5 Injection to patients exhibiting severe hepatic impairment requires careful monitoring. A modified dosage of Nvixo-S 1.5 Injection may be necessary; physician consultation is advised. Dosage alteration for Nvixo-S 1.5 Injection is unnecessary in individuals with mild or moderately compromised liver function.
What if you forget to take Nvixo-S 1.5 Injection :
Should you forget a scheduled dose of Nvixo-S 1.5 Injection, seek medical advice.
Facts to Know About Nvixo-S 1.5 Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
